Biotech entity
fda-approval is the sole category represented across all 1 tracked stories. Bespoke Gene Therapy Consortium is most often covered alongside CBER, which appears in 1 of these 1 story. Bespoke Gene Therapy Consortium appears in 1 tracked Biotech story from February 24, 2026.
Last mentioned: Feb 24, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
fda-approval is the sole category represented across all 1 tracked stories. Bespoke Gene Therapy Consortium is most often covered alongside CBER, which appears in 1 of these 1 story. Bespoke Gene Therapy Consortium appears in 1 tracked Biotech story from February 24, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bespoke Gene Therapy Consortium. Shared-story counts are live from our verified record — not editorial picks.
Formal Proposal
FDA formally proposes the new customized drug approval system for ultra-rare diseases.
BGTC Pilot Completion
The Bespoke Gene Therapy Consortium completes its first round of pilot manufacturing runs.
Draft Guidance Issued
FDA releases initial thoughts on 'n-of-1' therapy development and manufacturing.
PREVENT Act Passed
Congress directs FDA to establish a framework for platform technology designations.
The FDA has proposed a landmark regulatory framework to streamline the approval of customized, 'n-of-1' therapies for ultra-rare diseases. By shifting focus from individual products to validated manufacturing platforms, the agency aims to drastically reduce the time and cost of bringing genetic treatments to patients with unique mutations.
Bespoke Gene Therapy Consortium is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
